Safety, Tolerability and Pharmacokinetic Studies of HRS-2183 for Injection in Healthy Chinese Subjects After Single and Multiple Administration

Clinical trial NCT07232758 · RECRUITING

Trial details

NCT number: NCT07232758
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Chinese Healthy Adult Subjects

Start date: 2025-10-30
Primary completion: 2026-02-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.